Unexpected common mechanistic pathways for embryotoxicity of warfarin and lovastatin
2010
Groebe, K. | Hayess, K. | Klemm-Manns, M. | Schwall, G. | Wozny, W. | Steemans, M. | Peters, A.K. | Sastri, C. | Jaeckel, P. | Stegmann, W. | Zengerling, H. | Schopf, R. | Poznanovic, S. | Stummann, T.C. | Seiler, A. | Spielmann, H. | Schrattenholz, A.
German. Novel molecular content for fast in vitro strategies in the context of safety tests concerning developmental toxicity has a potential to substantially reduce animal experiments according to the "3R" concept (Reduce/Refine/Replace). Here we present and discuss data from a differential proteomic profiling of samples generated using embryonic stem cell drived in vitro models treated with a set of model substances. Among substance-dependent proteomic changes, potential surrogate markers were some isoforms of heat shock proteins and a component of the Ras pathway, present in several redundant isoforms due to posttranslational modifications. Both proteins are implicated in cell migration, cell survival, growth and embryonic development. Using the examples of Warfarin and Lovastatin, two substances with entirely different primary targets, the surrogate marker signature nevertheless indicates a common embryotoxic mode of action We discuss these findings observed in in vitro toxicity tests, in a context of clinical validation and evidence-based toxicology
Show more [+] Less [-]AGROVOC Keywords
Bibliographic information
Publisher Elsevier
ISSN 0890-6238This bibliographic record has been provided by German Federal Institute for Risk Assessment